Zhengye Biotechnology Holding Ltd balance sheet

At the end of fiscal 2025, Zhengye Biotechnology Holding Ltd had total assets of $62.4m, total liabilities of $18.6m and shareholders' equity of $35.7m. It held $7.2m in cash against $10.7m of debt: net debt of $3.5m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Zhengye Biotechnology Holding Ltd: balance sheet, annual
Fiscal year	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	1	2	3	7
Receivables	—	10	8	3
Inventory	—	8	8	6
Total current assets	—	27	24	20
Total assets	—	70	68	62
Accounts payable	—	6	6	6
Deferred revenue (current)	—	1	0	1
Total current liabilities	—	21	19	17
Short-term debt	—	11	1	0
Long-term debt	—	1	1	1
Total debt	0	13	12	11
Total liabilities	—	23	19	19
Shareholders' equity	52	38	39	36
Non-controlling interests and other (assets − liabilities − equity)	—	9	9	8
Net debt (negative = net cash)	−1	11	9	3
Shares outstanding	—	46m	46m	—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: SLGL vs ZYBT JAGX vs ZYBT VRCA vs ZYBT

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Zhengye Biotechnology Holding Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Zhengye Biotechnology Holding Ltd.